Quest Partners LLC Dyne Therapeutics, Inc. Transaction History
Quest Partners LLC
- $1.02 Trillion
- Q2 2025
A detailed history of Quest Partners LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 18,317 shares of DYN stock, worth $181,521. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,317
Previous 16,332
12.15%
Holding current value
$181,521
Previous $171 Million
2.08%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding DYN
# of Institutions
217Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$103 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$96.3 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$90.5 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$73.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$73.2 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $513M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...